Ovidiu Cotoi (Former)
1 – 7 of 7
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Short-term S100A8/A9 Blockade Promotes Cardiac Neovascularization after Myocardial Infarction
2024) In Journal of Cardiovascular Translational Research(
- Contribution to journal › Article
- 2023
-
Mark
S100A8/A9 is a valuable biomarker and treatment target to detect and modulate neutrophil involvement in myocardial infarction
(
- Contribution to journal › Article
- 2021
-
Mark
Studying the innate immune response to myocardial infarction in a highly efficient experimental animal model
(
- Contribution to journal › Article
- 2018
-
Mark
Innate immune mechanisms in myocardial infarction - An update
(
- Contribution to journal › Scientific review
- 2014
-
Mark
Plasma S100A8/A9 Correlates With Blood Neutrophil Counts, Traditional Risk Factors, and Cardiovascular Disease in Middle-Aged Healthy Individuals.
(
- Contribution to journal › Article
- 2013
-
Mark
S100A8 and S100A9: DAMPs at the crossroads between innate immunity, traditional risk factors, and cardiovascular disease.
(
- Contribution to journal › Scientific review
-
Mark
Plasma procalcitonin is associated with all-cause and cancer mortality in apparently healthy men: a prospective population-based study.
(
- Contribution to journal › Article